GeneDx Holdings Corp.
Healthcare · Diagnostics & Research
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Open an account and get free stocks
Affiliate disclosure: We may receive compensation when you sign up through these links.
68
Total Trades
68
Buy Orders
1.33M shares
0
Sell Orders
0.00M shares
+1.33M
Net Position
| Date | Type | Fund | Shares | % of Fund |
|---|---|---|---|---|
| Apr 9 | Buy | ARKG | 14,111 | 0.080% |
| Apr 9 | Buy | ARKK | 18,656 | 0.019% |
| Apr 8 | Buy | ARKG | 5,894 | 0.037% |
| Apr 8 | Buy | ARKK | 6,622 | 0.007% |
| Apr 7 | Buy | ARKG | 1,997 | 0.012% |
| Apr 7 | Buy | ARKK | 2,124 | 0.002% |
| Apr 2 | Buy | ARKG | 1,307 | 0.008% |
| Apr 2 | Buy | ARKK | 1,562 | 0.002% |
| Apr 1 | Buy | ARKG | 5,162 | 0.032% |
| Apr 1 | Buy | ARKK | 5,943 | 0.006% |
| Mar 31 | Buy | ARKG | 2,060 | 0.013% |
| Mar 31 | Buy | ARKK | 2,499 | 0.003% |
| Mar 30 | Buy | ARKG | 9,602 | 0.058% |
| Mar 30 | Buy | ARKK | 11,072 | 0.012% |
| Mar 13 | Buy | ARKG | 2,612 | 0.019% |
| Mar 13 | Buy | ARKK | 3,405 | 0.004% |
| Mar 12 | Buy | ARKG | 22,382 | 0.161% |
| Mar 12 | Buy | ARKK | 29,693 | 0.036% |
| Mar 11 | Buy | ARKG | 1,202 | 0.009% |
| Mar 11 | Buy | ARKK | 1,620 | 0.002% |
| Mar 10 | Buy | ARKG | 3,040 | 0.024% |
| Mar 10 | Buy | ARKK | 3,788 | 0.005% |
| Mar 9 | Buy | ARKG | 39 | 0.000% |
| Mar 9 | Buy | ARKK | 53 | 0.000% |
| Mar 6 | Buy | ARKG | 3,960 | 0.029% |
| Mar 6 | Buy | ARKK | 5,153 | 0.006% |
| Mar 5 | Buy | ARKG | 11,168 | 0.075% |
| Mar 5 | Buy | ARKK | 14,821 | 0.018% |
| Mar 4 | Buy | ARKG | 17,596 | 0.119% |
| Mar 4 | Buy | ARKK | 21,531 | 0.026% |
| Mar 3 | Buy | ARKG | 25,323 | 0.163% |
| Mar 3 | Buy | ARKK | 32,043 | 0.037% |
| Feb 4 | Buy | ARKK | 36,065 | 0.048% |
| Feb 3 | Buy | ARKG | 29,623 | 0.226% |
| Feb 3 | Buy | ARKK | 53,607 | 0.079% |
| Feb 2 | Buy | ARKG | 35,777 | 0.278% |
| Feb 2 | Buy | ARKK | 65,442 | 0.097% |
| Jan 30 | Buy | ARKK | 91,785 | 0.124% |
| Jan 12 | Buy | ARKG | 20,478 | 0.194% |
| Jan 12 | Buy | ARKK | 112,713 | 0.189% |
| Date | Type | Fund | Shares | % of Fund |
|---|---|---|---|---|
| Dec 9 | Buy | ARKG | 1,653 | 0.020% |
| Dec 8 | Buy | ARKG | 4,289 | 0.053% |
| Dec 8 | Buy | ARKK | 3,304 | 0.007% |
| Dec 5 | Buy | ARKG | 31,296 | 0.377% |
| Dec 5 | Buy | ARKK | 20,200 | 0.041% |
| Dec 4 | Buy | ARKG | 6,033 | 0.076% |
| Dec 4 | Buy | ARKK | 3,453 | 0.007% |
| Dec 3 | Buy | ARKG | 15,064 | 0.199% |
| Dec 3 | Buy | ARKK | 8,660 | 0.019% |
| Nov 24 | Buy | ARKG | 6,744 | 0.091% |
| Nov 24 | Buy | ARKK | 4,070 | 0.009% |
| Nov 21 | Buy | ARKG | 7,442 | 0.094% |
| Nov 21 | Buy | ARKK | 4,738 | 0.010% |
| Nov 20 | Buy | ARKG | 7,887 | 0.097% |
| Nov 20 | Buy | ARKK | 4,900 | 0.009% |
| Oct 16 | Buy | ARKG | 17,134 | 0.158% |
| Oct 6 | Buy | ARKG | 19,875 | 0.202% |
| Aug 19 | Buy | ARKG | 1,667 | 0.019% |
| Aug 19 | Buy | ARKK | 124,669 | 0.174% |
| Aug 18 | Buy | ARKG | 2,900 | 0.034% |
| Aug 18 | Buy | ARKK | 167,571 | 0.208% |
| Aug 15 | Buy | ARKG | 632 | 0.007% |
| Aug 15 | Buy | ARKK | 48,224 | 0.046% |
| Aug 14 | Buy | ARKG | 284 | 0.003% |
| Aug 14 | Buy | ARKK | 25,127 | 0.030% |
| Aug 13 | Buy | ARKG | 17,723 | 0.205% |
| Aug 12 | Buy | ARKG | 20,490 | 0.236% |
| Aug 6 | Buy | ARKG | 23,005 | 0.243% |